Hillsdale Investment Management Inc.
Position in ANIK — Anika Therapeutics, Inc.
CIK 1368465
Toronto, A6
Position in ANIK
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$368,300
New position
Shares Held
25,400
first reported quarter
Ownership
0.191%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Hillsdale Investment Management Inc. holds $35,500,367 across 9 Drug Manufacturers - Specialty & Generic names. ANIK ranks #8 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMRX |
Amneal Pharmaceuticals, Inc.
|
743,679 | $9,243,929 | |
| 2 | PCRX |
Pacira BioSciences, Inc.
|
331,300 | $7,487,380 | |
| 3 | COLL |
Collegium Pharmaceutical, Inc
|
184,600 | $6,104,722 | |
| 4 | BCRX |
Biocryst Pharmaceuticals Inc
|
639,100 | $6,084,232 | |
| 5 | IRWD |
Ironwood Pharmaceuticals Inc
|
1,236,628 | $4,340,564 | |
| 6 | VTRS |
Viatris Inc
|
107,800 | $1,456,378 | |
| 7 | PAHC |
Phibro Animal Health Corp
|
7,500 | $414,825 | |
| 8 | ANIK |
Anika Therapeutics, Inc.
This page
|
25,400 | $368,300 |
All Filings in ANIK
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $368,300 | 25,400 | Shares | Sole | 2026-05-04 | |
| No filing history on record for this holder in this stock. | ||||||